




DESIGN, SYNTHESIS AND VALIDATION OF CqsS RECEPTOR AGONIST TO MODULATE THE 
QUORUM SENSING CIRCUIT OF VIBRIO CHOLERAE–A MOLECULAR MIMIC THERAPY 
 
HEMA M.1, JADAV SAIKIRAN1, KAMLESWAR C.1, V. SRIDHARAN2, GURMEET KAUR1, P. BALAMURUGAN1, 
SUMANA M. N.3, ADLINE PRINCY S.1* 
1Quorum Sensing Laboratory, Centre for Research on Infectious Diseases (CRID), School of Chemical and Biotechnology, 2School of 
Chemical and Biotechnology, SASTRA University, Thanjavur-613401, Tamil Nadu, India, 3
Received: 02 May 2015 Revised and Accepted: 22 Sep 2015 
ABSTRACT 
Objective: Our earlier studies have characterized a compound from Melia dubia leaves, 4-ethyl resorcinol as an agonist of the Quorum Sensing (QS) 
receptor, CqsS agonist that had reverse engineered the QS circuit of V. cholerae from low-density to high-density state to effectively inhibit biofilm 
and enhance the production of protease to detach itself form the host tissue. So, the objective of this study was to synthesize structural derivatives 
of 4-ethyl resorcinol, to enhance its activity and to down regulate the host cell toxicity was validated. 
Methods: The antimicrobial (cell-density) and anti-virulent (protease, hemolysis, stress responds and biofilm inhibition) properties of the 
structural derivatives of 4-ethyl resorcinol were performed. 
Results: The results indicate that the compound has up surged protease expression along with a remarkable decrease in hemolytic activity at the 7
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hour. The stress responds in treated culture has a higher survival rate while the bacterial cells in the control succumb to stress stating the potential 
of the drug to induce HCD (high cell density) condition in the LCD (low cell density) state. From CLSM analysis we state that there was significant 
amount of dead colonies and disrupted biofilm in the respective treated culture 
Conclusion: This could possibly open up a direction to curb the bacterial biofilm formation and may also turn out to be a potent drug against 
treating Vibrio cholerae infection at an early point 
 
INTRODUCTION 
Vibrio cholerae, Biofilm. 
Cholera is solely an intestinal diarrheal disease caused by Vibrio 
cholerae, rod-shaped, Gram-negative bacteria [1]. Antibiotics 
(tetracycline, doxycycline, etc.,) are useful adjuncts in treatment that 
shortens the infection time with the pathogen. The distinct 
behavioral pattern of any bacteria to their diverse milieu is an effect 
of the communication scheme between them known as the Quorum 
Sensing (QS). Chemical molecules called “Auto-Inducers” serve as 
the bacterial lingo. In common, most bacteria show to produce 
appropriate output at a high cell density (HCD) but surprisingly 
reverse condition is persisting in the case of V. cholerae i.e. under 
conditions of Low Cell Density (LCD) virulence factors are expressed 
and at HCD, repression occurs. Additionally, at HCD activation of 
HapA (Haemagglutinin Protease) occurs which facilitates the 
dissemination of the bacterial cells from the human intestinal cells. 
The inter-species QS System-I and intra-species QS System-II 
responds to signals, AI-2 and CAI-1 respectively. 
The lower concentration of the auto-inducer signals leads to an 
inefficient binding to their cognate receptor CqsS or LuxPQ 
respectively. Consequently, receptors serve as kinases and initiate a 
cascade of mechanisms which make the Qrr1-4 to bind with mRNA 
transcript of HapR. (A global virulence repressor protein in Vibrio 
cholerae). [2-6] and renders the translation of HapR impossible [6]. In 
LCD conditions, virulence factors like Cholera toxin, Toxin co-
regulated pilus, Haemolysin, Biofilm are expressed, but factors like 
HapA protease, σ[54]are repressed because of the absence of 
translation of HapR mRNA transcript [7-10]. Hence, it could be 
inferred that “virulence and signal concentration are inversely 
proportional” in the case of Vibrio cholerae. At HCD, the binding of CAI-
1 and AI-2 to the cognate receptors CqsS and Lux P/Q occur. This 
binding switches them to function as kinase to phosphatase enzymes. 
Phosphatase activity leads to dephosphorylation of LuxO protein and 
brings about repression in qrr1-4 production. Qrr1-4 repression 
subsequently leads to a successful translation of HapR mRNA 
transcript. As a result, virulence factors like haemolysin, biofilm, 
cholera toxin, and toxin co regulated pilus are repressed and HapA 
protease and σ [54] are expressed at HCD conditions. Therefore, 
establishing QS (HCD Condition) in Vibrio cholera in a LCD state using 
either structural or functional quorum (receptor agonist) mimics 
molecules could be a novel approach to achieve an anti-virulent effect 
[11]. In this work, we had focused to increase the efficiency of an 
established mimic molecule 4-ethyl resorcinol derivatives, an ultimate 
plant-derived compound from Melia dubia [12]. 
MATERIALS AND METHODS 
Computational studies 
Homology modeling of Vibrio cholerae CqsS protein 
The amino acid sequence of the transmembrane CAI-1 receptor 
protein, CqsS of Vibrio cholerae El tor (Uniprot Accession Number: 
Q9KKM66) was loaded into modeler 9v8 and searched for homology 
using BLAST homology search options in Schrodinger Maestro. The 
protein that had the maximum conserved sequences to CqsS 
receptor was chosen as the template and 10 models were generated 
independently in the modeler. The model with the least Root Mean 
Square Deviation (RMSD) value was selected. 
Ligand and protein preparation 
4 Structural derivatives of 4-Ethyl resorcinol that are to be synthesized 
were drawn using ACD Chemsketch. The energy minimized 3D ligand 
file was developed for docking using Schrödinger Lig Prep software. 
The modeled CqsS was prepared for docking by using protein 
preparation wizard of Schrödinger Maestro. Receptor grid was 
generated encompassing the sites with 0.375Å spacing. 
Molecular docking 
Docking studies were conducted using the Glide application of 
Schrödinger Maestro. Ligands and the prepared protein files were 
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imported and docked using XP precision. Glide score for all the four 
compounds was named and registered 
Chemical synthesis 
Structural derivatives of 4-Ethyl resorcinol are synthesized by 
condensation reactions. 4-ethyl resorcinol has two hydroxyl groups 
at ortho and para positions. Both individual and double replacement 
of these hydroxyl groups using benzyl and benzoyl groups is 
performed. Initially, one equivalent (500 mg) of 4-Ethyl resorcinol 
was added with one equivalent (618.99 mg) of benzyl bromide in 
the presence of potassium carbonate (600.03 mg). The mixer was set 
aside to shift in a magnetic stirrer for 24 h at room temperature. The 
product was then parted from the reaction mixer using the column 
chromatography. Then the same reaction was carried away with two 
equivalents of benzyl bromide (1.2g) to bring the double substitution 
product. The subsequent reactions were taken away with one 
equivalent of benzoyl chloride (508.58 mg) and two equivalents of 
benzoyl chloride (1.017g) as second starting material to generate the 
desired product. One equivalent of 4-ethyl resorcinol with one 
equivalent of benzyl bromide yielded 5-(benzyloxy)-2-ethylphenol 
and with two equivalents of benzyl bromide yielded 4-ethyl-1,3-
phenylene) bis (Oxy) bis (methylene) dibenzene. (fig. 1 and fig. 2). 
 
Fig. 1: Scheme for the synthesis of CqsSER-1 
 
 
Fig. 2: Scheme for the synthesis of CqsS ER-2 
 
One equivalent of 4-ethyl resorcinol with one equivalent of benzoyl 
chloride yielded 4-ethyl-3-hydroxyphenyl benzoate and two 
equivalents of benzoyl chloride yielded 4-ethyl-1,3-phenylene 
benzoate. (fig. 3 and fig. 4). Proton NMR was carried out to confirm 
the synthesis of compounds. 
 
Fig. 3: Scheme for the synthesis of CqsS ER-3 
 
Bacterial survival and growth assay 
Fresh inoculum of Vibrio cholerae O1 MTCC 3906 collected from 
Microbial Type Culture Collection Centre, Chandigarh in Luria Broth 
was prepared at the dilution rate of 1:100 from an overnight culture. 
The number of colonies at the exponential stage was determined by 
plating the samples from the inoculum on LB agar plates. The 
culture at the exponential stage was then seeded in a microliter 
plate with each well supplemented with varying concentration (2, 4, 
6, 8, 10, 50, 100, 120, 140, 150µg/ml) of the four test compounds in 
triplicates. The optical density was observed at 600 nm to observe 
the bacterial growth at the time of seeding in the microtiter plate. 
The plate was then left for 24 h to examine the bactericidal effect of 
the test compounds. After 24 h optical density were observed at 600 
nm to calculate the bacterial growth and at the same hour plating of 
samples was carried out on LB agar plates from the samples taken 
from each well to determine the number of colonies survived. The 
Gompertz growth curve equation percentage of bacterial survival 
was used for analysis [13]. 
 
Fig. 4: Scheme for the synthesis of CqsS ER-4 
 
Biofilm inhibition assay  
The assay was carried out as described in Ravichandiran Vet al.[14]. 
In this assay, 10 µl of the Vibrio cholerae O1 MTCC 3906 culture was 
added to the wells in a 96-well microtitre plate along with 100 µl of 
LB medium and 100 µl of varying concentrations (2, 4, 6, 8, 10, 50, 
100, 120, 140, 150µg/ml) of all the four compounds in triplicates. 
The plate was incubated at room temperature for 24 h. Then 
planktonic cells were washed off. Further the step was followed by 
washing the wells twice with de-ionized water. 210 µl of 0.1% 
Crystal Violet (w/v) was added to the wells and a short incubation 
time of 10 min was given. The dye was discarded and the wells were 
again washed twice with de-ionized water. Finally, the crystal violet 
adhering to the biofilm was solubilized in 210 µl of Dimethyl 
Sulphoxide (DMSO). Optical Density (OD) was measured at 595 nm 
in Bio Rad i-Mark microplate reader. A graph between percentages 
of inhibitions versus the various concentrations of these compounds 
were plotted to calculate the minimum biofilm inhibitory (MBIC). 
Biofilm eradication assay 
In this assay, 100 µl of Vibrio cholerae O1 MTCC 3906 culture was 
added to a 96-well microtitre plate having 100 µl of LB medium and 
incubated for 24 h at room temperature. Plank tonic cells were 
removed from all wells and the respective wells were treated with 
the compounds at varying concentrations (2, 4, 6, 8, 10, 50, 100, 120, 
140, 150µg/ml) and incubated for 30 min at room temperature. The 
assay was carried out in triplicates. The minimum biofilm 
eradication (MBEC) was calculated and a graph was plotted between 




Azocasein assay was employed for quantitative estimation of 
protease as described by Hasegawa Het al.[15]. The cell 
supernatants of Vibrio cholerae O1 MTCC 3906 of both treated and 
untreated with two concentrations of drug (EC50 and EC90), native 
CAI-1 and 4-Ethyl resorcinol were obtained by centrifugation the 
culture tubes at 2600rpm/10 min/4 °C. 200 µl of the supernatant 
was incubated with 800 µl of Azocasein for 30 min at 37 °C. For this 
volume, 1200 µl of 1% Tri Chloro Acetic Acid (TCA) was added to 
arrest the enzymatic reaction. Ice incubation for 30 min was done 
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and it was centrifuged at 13000rpm/5 min. To 1600 µl of this 
supernatant, 400 µl of 1.8N NaOH was added. Optical density was 
measured at 420 nm against the blank (Azocasein+TCA+NaOH). One 
unit of protease activity is defined as the amount of enzyme required 
to digest 1 mg of azocasein in 1 min.  
% proteolysis =




The procedure was a modified version of the assay carried by 
Fagerlund A et al.[16]. 10 ml of sheep blood was centrifuged at 
2400rpm for 5 min. The pellet obtained was washed twice with 10 
ml Phosphate Buffer Saline (PBS). 10 µl of this erythrocyte 
suspension was incubated with the cell supernatants of Vibrio 
cholerae O1 MTCC 3906 (untreated-control) and treated with two 
effective concentrations of the drug (EC50 and EC90
The assay was based on stress response of the Vibrio cholerae to 
H
), native CAI-1 
and 4-Ethyl resorcinol (that was previously obtained by 
centrifugation of the cell culture sample at 12400rpm/10 min/20 
°C) for 1 hour at 37ºC. Finally, the incubated sample was centrifuged 
at 2400 rpm/5 min. The optical density of the supernatant obtained 
was read at 540 nm using 1 % Triton X as the positive control. Water 
along with the erythrocyte suspension was considered to be the 
blank. % Haemolysis was calculated using the following formula:  
% Haemolysis =
Absorbance (Sample)− (Absorbance Blank
Absorbance (Positive Control)
 
Stress response assay 
2O2 17[ ]. 15 mM H2O2 was incubated with Vibrio cholerae O1 
MTCC 3906 both untreated and treated groups with two 
concentrations of drug (EC50 and EC90), native CAI-1, 4-Ethyl 
resorcinol for various time intervals (30 min & 60 min).  
The percentage survival counts were calculated based on time zero 
and indicated time points plate counts. The experiment was 
repeated for LCD (7th hour sample), HCD (15th hour sample) and 
crude CAI-1 treated. The stress response profile was evaluated 
based on plotting a graph of percentage survival versus time for 
culture samples treated with various moieties. The increased stress 
response correspond to the production of RpoS (RNA Polymerase 
Sigma Factor–σ[54]) which in turn is activated by Hap R. The assays 
were done in order to confirm the binding of CAI-1 mimic molecule. 
to activate the production of Hap R and reverse engineer the 
quorum sensing circuit of Vibrio cholerae from LCD to HCD state. 
Cell cytotoxic studies 
Hep-G2 cells were seeded in 48 well plates at a seeding density of 
15,000 cells/well. The cells were checked for its confluence, once it 
has attained 70% of confluence, the MBIC50 (10µg/ml) and 
2XMBIC50 (20µg/ml) concentrations of the synthesized drug was 
added. After 24 h of incubation, the supernatant was used for LDH 
(Lactate Dehydrogenase) assay.  
Lactate dehydrogenase (LDH) assay 
Cytotoxicity of the synthesized drug at its varying concentration was 
determined by lactate dehydrogenase (LDH) assay. The assay 
determined the release of cytoplasmic lactate dehydrogenase into 
the cytosol due to the leakage of the damaged cells. After 24 h of 
incubation, 50 µl of culture medium was collected and incubated 
with the reaction mixture consisting of NAD+
The overnight culture of the Vibrio cholerae O1 MTCC 3906 was 
diluted 1:100 in a fresh medium of TSB. The cover slips were placed 
in sterile 96-well plates and diluted culture was added in the cover 
slip placed in the wells. A well with the diluted culture without drug 
as a negative control, with 4-Ethyl resorcinol as positive control and 
the test wells with diluted culture were supplemented with two 
different concentrations of the compounds (EC
(50 µl), lactate (50 µl) 
and phosphate buffer (0.2 M) pH 7.4. The absorbance was measured 
at 340 nm. 
Confocal laser scanning microscopy analysis of biofilm 
50 and EC90
18
). After the 
biofilms were grown for 18h, the suspension was aspirated and 
removed carefully. The biofilm was rinsed delicately in 0.9% NaCl 
solution. Stock solutions of fluorescein isothiocyanate (5 mg/ml) 
and ethidium bromide (1.25 mg/ml) were prepared beforehand. 5 µl 
each of the dyes were mixed with 1 ml of cold 0.9% NaCl solution to 
obtain the working solution. The biofilm was dyed with 5 µl of the 
working solution of the dyes for 10 min, and then the excess dye was 
removed by washing with 0.9% NaCl. The cover-slip was then dried 
for 2 min at ambient temperature and then fixed using 50 µl of 
toluene. Confocal imaging was performed at wavelengths around 
500 nm using Olympus Confocal Laser Scanning Microscope to 
obtain the live/dead imaging [ ]. 
RESULTS  
Docking results 
Molecular docking studies demonstrated the high binding affinity 
(Least G Score) for 4-Ethyl Resorcinol (Positive control) and its 
derivatives (CqsS ER-1, CqsS ER-2, CqsS ER-3, CqsS ER-4) towards 
the CqsS receptor model. It has been proved already that both 4-
ethyl resorcinol and native CAI-1 binds in the same binding pocket 
in CqsS. (His 73 residues). Interaction pattern of these ligands with 
CqsS receptor (table 1) showed that among all four ligands CqsS ER-
1 had higher a binding affinity and made similar interactions with 
His73 residue as in the case of native CAI-1 and 4-Ethyl resorcinol. 
ADME property 
Absorption, Distribution Metabolism, Excretion are the four basic 
criteria that influence the drug levels and their kinetics of exposure to 
the tissues. This greatly influences the pharmacological activity of the 
drug. ADME results obtained from all the four compounds were 
tabulated (table 1). Rule of five evaluates drug likeness of a chemical 
compound with some pharmacological activity and its ability to be an 
orally active drug for human being. According to this rule a 
hydrogen bond
drug to be 
orally active should not have more than one violation of the following 
criteria. Not more than 5  donors and 10 hydrogen 
bond acceptors. The molecular mass of the compound should be less 
than 500 daltons and the octanol-water partition coefficient log P not 
greater than 5. It was found that all ligands except CqsS ER-2 showed 
to be cooperative for drug-likeness property. 
Proton NMR  
Synthesized compounds were confirmed using proton NMR. 
Samples were dissolved in CDCl3 for analysis by proton nuclear 
magnetic resonance. The NMR results for all the four compounds are 
as follows. 
CqsS ER1-5-(benzyloxy)-2-ethylphenol 
Yield 79%, 1H–NMR (CDCl3), 300Hz): δ: 1.23 (t, J = 7.5 Hz, 3H), 2.57 
(q, J = 7.5, 2H), 4.28 (s, 1H), 5.02 (s, 2H), 6.45 (d, J = 2.4 Hz, 1H), 6.25 
(dd, J = 8.4Hz, 2.4 Hz, 1H), 7.03 (d, J = 8.4 Hz, 1H), 7.32-7.43 (m, 5H) 
CqsS ER2-4-ethyl-1,3-phenylene)bis(oxy)bis(methylene) dibenzene 
Yield 65%, 1H–NMR (CDCl3), 300Hz): δ: 1.20 (t, J = 7.5 Hz, 3H), 2.65 (q, 
J = 7.5, 2H), 5.03 (s, 2H), 5.03 (s, 2H), 6.53 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 
6.6 (d, J = 2.4 Hz, 1H), 7.07 (d, J = 8.4 Hz, 1H), 7.32-7.45 (m, 10H) 
CqsS ER3-4-ethyl-3-hydroxyphenyl benzoate 
Yield 84%, 1H–NMR (CDCl3), 300Hz): δ: 1.24 (t, J = 7.5 Hz, 3H), 2.63 
(q, J = 7.5, 2H), 5.11 (s, 2H), 6.67 (d, J = 2.1 Hz, 1H), 6.73 (dd, J = 8.4 
Hz, 2.7 Hz, 1H), 7.16 (d, J = 8.4 Hz, 1H), 7.50 (t, J = 7.5Hz, 2H) 7.64 (t, 
J = 7.3Hz, 1H) 3.19 (d, J= 7.5 Hz, 2H). 
CqsS ER4-4-ethyl-1,3-phenylene dibenzoate 
Yield 73%, 1H–NMR (CDCl3
The CqsS agonist effect over Vibrio cholerae growth and survival was 
carried out to optimize the minimum inhibitory concentrations. At 
concentrations below the NIC, growth occurs at a pace equal to the 
control and the Gompertz model was used to ascertain the MIC and 
), 300Hz): δ: 1.23 (t, J = 7.5 Hz, 3H), 2.64 
(q, J = 7.5, 2H), 7.11-7.14 (m, 2H), 7.36 (d, J = 9 Hz, 1H), 7.48-7.56 (m, 
4H), 7.61-7.66 (m, 2H), 8.18-8.24 (m, 4H). 
Bacterial growth and survival 
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NIC values. The increasing concentration of all four CqsS agonist 
showed considerable decline in their growth. Further the NIC and 
MIC values obtained from the graph were tabulated (table 2). 
Biofilm Inhibitory and Biofilm Eradication 
The CqsS agonists were tested with varying concentrations for their 
biofilm inhibitory and eradication capacity. The MBIC50 and MBEC50
Selection of the most credible compound 
 
values for all four CqsS agonist were tabulated (table 3). 
These results suggest that the biofilm eradication concentration is 
much lower than the bactericidal concentration of the compounds 
CqsS ER-1, CqsS ER-3, CqsS ER-4. This proposes that these 
compounds have high potential in eradicating the biofilm at a much 
lower concentration by altering the quorum sensing pathway. 
In accordance with the docking and in vitro studies, the effect of all 
four CqsS agonist on Vibrio cholerae survival and biofilm 
eradication results ‘CqsS ER-1’ was chosen as the best. It had a 
higher binding affinity (-3.80) and was found to bind to the same 
binding pocket where the native CAI-1 and the proven mimic 
molecule 4-ethyl resorcinol binds (His 73 residue). Its biofilm 
inhibitory concentration was also found to be within the non-
inhibiting concentration which proves that this compound was not 
lethal but suppresses the biofilm formation. The CqsS ER-1 was 
further taken to characterize its mode of action as a CqsS agonist 
to reverse the LCD (low cell density state) to HCD (High Cell 
Density) state. 
 
Table 1: Structure, interaction pattern and ADME property of the CqsS agonists 




























Positive 346.382 Positive Positive Positive 5.91 
- Toxic free behavior 
 
Table 2: The non-inhibitory (NIC) and minimum inhibitory 
(MIC) concentration of CqsS agonist on growth of V. cholerae 
Compound MNIC (µg/ml) MIC (µg/ml) 
CqsS ER-1 21.48 332.1 
CqsS ER-2 6.94 8.30 
CqsS ER-3 5.27 83.98 
CqsS ER-4 40.34 114.1 
 
Table 3: The minimum biofilm inhibition (MBIC) and 
eradication (MBEC) concentration of the CqsS agonist 
Compound MBIC50 MBEC (µg/ml) 50 (µg/ml) 
CqsS ER-1 10 6 
CqsS ER-2 8 8 
CqsS ER-3 6 8 
CqsS ER-4 4 50 
 
Protease assay 
Protease assays were carried out to confirm the activity of the cell 
signaling mimic molecule ‘CqsS ER-1’ to reverse the LCD state to 
HCD state. Protease assay was performed with the two 
concentrations of the compound (MBEC50, MBEC90
 
Fig. 5: Effect of CqsS agonist (EC
) and with native 
CAI-1 & 4-ethyl resorcinol as positive controls. Results (fig. 5) 
indicate that the compound has up surged protease expression. 
 
50 and EC90) on reversing the 
phosphate flow to turn on the protease production. (Positive 
Control-4-Ethyl resorcinol; native CAI-1) 
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The graph was plotted in accordance with the values obtained from 
two ways Anova and the asterisk in the graph shows the 
significance. This is a characteristic attribute of a high cell density 
condition as there is a dephosphorylation of LuxO protein, which 
brings about repression in qrr1-4 production. Qrr1-4 repression 
subsequently leads to a successful translation of HapR mRNA 
transcript and as a result, HapA protease was expressed. 
 
 
Fig. 6: Effect of CqsS agonist (EC50 and EC90) on reversing the 
phosphate flow to turn off the hemolysin production. (Positive 
Control-4-Ethyl resorcinol; native CAI-1) 
 
Hemolytic activity 
Under LCD conditions (7th hour from inoculation), haemolysin is 
expressed because of the absence of translation of HapR mRNA 
transcript. Hemolytic assay was carried out with the two 
concentrations of the compound (MBEC50, MBEC90) and with native 
CAI-1 and 4-ethyl resorcinol as positive controls. The results in fig. 6 
suggest that there is a remarkable decrease in the haemolytic activity 
at the 7th hour of growth which is proposed to be the LCD state. This 
again clearly shows that the LCD conditions had been reversed to HCD 
state. The graph was plotted in accordance with the values obtained 
from two way Anova and the * in the graph shows the significance.  
Stress response assay 
Vibrio cholerae O1 MTCC 3906 was subjected to stress, in addition to15 
mM H2O2. At HCD state successful translation of HapR mRNA transcript 
results in the production of HapR protease, as well as ‘σ[54]’
 
Fig. 7: Effect of CqsS agonist (EC
the stress 
response factor. The stress response factor helps in survival of bacteria 
under the stress conditions. The results (fig. 7) obtained suggest that the 
bacterial cultures seeded with the compound (CqsS ER-1) has a higher 
survival rate while the bacterial cells in the control succumb to stress 
stating the potential of the drug to induce HCD condition in the LCD 
state. The treatment with 4-Ethyl resorcinol and native CAI-1 is used as 
positive controls in the experiment. 
 
50 and EC90) on responding to 
stress induced with H2O2. 
The LDH assay was carried out to determine the viability of cells by 
the concentration of LDH observed in the medium in addition the 
drug, CqsS ER-1. The LDH concentration in the medium without 
drug was taken as the control. It was found that the concentration 
values for control (0.501 IU/l) and the two drug concentrations 
(EC
(Positive Control-4-Ethyl resorcinol; 
native CAI-1) 
 
Cell Cytotoxicity studies 
50= 0.4630 IU/l and EC90= 0.4630 IU/l) were almost same. This 
shows that the compounds did not involve in cell lysis stating that 
the compound is non-toxic at both concentrations. 
CLSM analysis of biofilm 
The CLSM analysis of Vibrio cholerae biofilm on treatment with 4-
Ethyl resorcinol (Positive control) significant amount of dead 
colonies and disrupted biofilm were witnessed. Whereas, more 
dead colonies and highly inhibited biofilm was observed on 
treatment with the drug, CqsS ER-1 (EC 50 and EC 90
 
Fig. 8: CLSM analysis of the CqsS agonist (EC
). It was also 
observed that the effect of lower concentration CqsS ER-1 did not 
show any significant effect as remained to be close to the positive 
control (fig. 8). 
 
50 and EC90) on the 
biofilm phenotype towards reversing the High Cell Density (HCD) 
to Low Cell Density (LCD) state. a. Negative Control; b. Positive 
Control-4-Ethyl resorcinol; c. CqsS-1 (EC50); d. CqsS-1 (EC90
The quorum quenching activity of CqsS ER-1 CqsS ER-1 possibly 
works through quorum sensing mechanism and prevents the biofilm 
formation. This work could open up a way to control the bacterial 
biofilm formation and ultimately aims at suppressing the virulence 
factors and pathogenicity during the early hours of an infection. In a 
synergistic approach with antibiotics, these compounds may prove 




The pathogen, Vibrio cholerae prominent to show biofilm-based 
infection to increase its resistance pattern over conventional 
antimicrobial agents and to evade the host intestinal system and the 
infection often turns out to be untreatable. As an alternative to 
conventional antibiotic therapy and to control multidrug resistance, 
we have established quorum sensing HCD Condition in Vibrio 
cholerae in a LCD state using the structural derivatives of a proven 
auto-inducer structural or functional mimic’s molecule known as 4-
ethyl resorcinol. Our in vitro data has proven that the chosen 
compound yielded results in a positive manner, establishing the 
potential of the drug. As early hours of growth i.e., at the LCD state 
where usually virulence is expressed in Vibrio cholerae bacterial 
cultures seeded with the compound showed significant changes in 
their behavior. Protease and stress response was considerably high, 
where as the production of hemolysin was repressed which is the 
characteristic nature of HCD state [19]. The biofilm inhibitory 
concentration of the drug is below the non-inhibiting concentration 
value, as a consequence of which the bacteria are not killed, whereas 
their virulence factors are repressed making it easy for the immune 
system to control the infection.  
CONCULSION 
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